Delivery Order SPE2DB20D3101-SPE2DB23FQVT0

Award Date 11/28/22
Potential Completion Date 11/29/22
Potential Value $3.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Norditropin FlexPro 30 mg/3 ml medical devices, with a ceiling value of $8,094.80 and a completion date of October 2, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a broad range of...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Norditropin FlexPro 30 mg/3 ml medication, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $7,014.24 and an ultimate completion date of August 31, 2021. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Norditropin FlexPro 30 mg/3 ml medication. The contract has a ceiling value of $1,169.06 and was awarded on May 10, 2022, with a completion date of May 11, 2022. The contract is a Delivery Order under a firm fixed-price structure and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Norditropin FlexPro 30 mg/3 ml, a specialty pharmaceutical product. The contract has a ceiling value of $5,941.72 and a completion date of September 12, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award, issued by the Defense Logistics Agency (DLA), is for the delivery of Norditropin FlexPro 10 mg/1.5 ml medication to support military healthcare programs. The $1,558.72 contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Norditropin FlexPro 30 mg/3 ml, a prescription medication. The contract has a ceiling value of $1,861.95 and an ultimate completion date of March 30, 2022. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,264.46, is for the delivery of Norditropin FlexPro 30 mg/3 ml 3 ml, a medical product, to support military healthcare programs. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,169.04, is for the delivery of Norditropin FlexPro 30 mg/3 ml injectable medication. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Norditropin Flexpro 30 mg/3 ml 3 ml. The award, a delivery order under contract SPE2DB22FH3V2, has a ceiling value of $10,275.09. The contract is a firm fixed-price agreement with a completion date of January 3, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Norditropin FlexPro 10 mg/1.5 mL. The contract has a ceiling value of $1,800.32 and a completion date of September 23, 2024. It is a firm-fixed-price contract and is not a set-aside. Amerisourcebergen is the prime contractor and there are no major subcontractors mentioned. This delivery order is part of a larger Indefinite Delivery...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FQVT0
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Norditropin FlexPro 30 mg/3 mL medication. The contract has a ceiling value of $3,321.08 and an ultimate completion date of November 29, 2022. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC is valued at up to $999,999,999.00 and runs through December 2025, serving as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense and other federal healthcare programs. The contract does not have a set-aside designation, indicating open competition. As a large pharmaceutical distributor, Amerisourcebergen plays a critical role in supplying essential medications and medical commodities to various government agencies, supporting the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 1:16 PM